A new therapeutic strategy for anti-donor specific antigen positive liver transplantation.
Project/Area Number |
16K20401
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Multi-year Fund |
Research Field |
Emergency medicine
|
Research Institution | Keio University |
Principal Investigator |
Mizota Takamasa 慶應義塾大学, 医学部(信濃町), 助教 (30649942)
|
Project Period (FY) |
2016-04-01 – 2018-03-31
|
Project Status |
Completed (Fiscal Year 2017)
|
Budget Amount *help |
¥3,120,000 (Direct Cost: ¥2,400,000、Indirect Cost: ¥720,000)
Fiscal Year 2017: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2016: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
|
Keywords | AMR / DSA / 抗体関連拒絶 / 肝移植 / AMR / 抗ドナー抗体 |
Outline of Final Research Achievements |
Outcomes of recipients who had preformed DSA was satisfactory and their DSA turned negative postoperatively. Recipients who developed do novo DSA was poor and AMR occured. Our immunosuppression protocol including portal infusion therapy may be associated with the prevention of AMR and de novo DSA.
|
Report
(3 results)
Research Products
(2 results)